Artwork

A tartalmat a Shawn Tassone MD PhD and Shawn Tassone MD PHD biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Shawn Tassone MD PhD and Shawn Tassone MD PHD vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.
Player FM - Podcast alkalmazás
Lépjen offline állapotba az Player FM alkalmazással!

86: Estradiol After 65 - Decreases Cancer and Dementia Prolongs Life

31:55
 
Megosztás
 

Manage episode 413248611 series 3462922
A tartalmat a Shawn Tassone MD PhD and Shawn Tassone MD PHD biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Shawn Tassone MD PhD and Shawn Tassone MD PHD vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

In this episode, Dr. Shawn Tassone discusses a recent study published in the Journal of the North American Menopause Society that challenges the previous negative views on hormone replacement therapy (HRT) for women over the age of 65.

The study found that HRT, specifically estrogen therapy, beyond the age of 65 is associated with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia. The study also highlighted the importance of individualized hormone therapy, lower doses, and non-oral routes of administration for optimal health outcomes.

Episode Highlights

  • Hormone replacement therapy (HRT) beyond the age of 65
  • Results of a new study published by NAMS
  • How they're associating HRT with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia
  • Individualized hormone therapy, lower doses, and non-oral routes of administration are recommended for optimal health outcomes.
  • Estrogen-only therapy, specifically transdermal estrogen with progesterone, is beneficial and prolongs life.
  • The study challenges the previous negative views on HRT for women over the age of 65 and provides evidence for the benefits of hormone therapy in improving women's health.
  • Why women should discuss hormone therapy options with their healthcare providers and consider the potential benefits and risks based on their individual needs and health conditions.

Resources

Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology

Dr. Shawn Tassone's Book | The Hormone Balance Bible

Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormonal Archtype Quiz

Medical Disclaimer

This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

  continue reading

106 epizódok

Artwork
iconMegosztás
 
Manage episode 413248611 series 3462922
A tartalmat a Shawn Tassone MD PhD and Shawn Tassone MD PHD biztosítja. Az összes podcast-tartalmat, beleértve az epizódokat, grafikákat és podcast-leírásokat, közvetlenül a Shawn Tassone MD PhD and Shawn Tassone MD PHD vagy a podcast platform partnere tölti fel és biztosítja. Ha úgy gondolja, hogy valaki az Ön engedélye nélkül használja fel a szerzői joggal védett művét, kövesse az itt leírt folyamatot https://hu.player.fm/legal.

In this episode, Dr. Shawn Tassone discusses a recent study published in the Journal of the North American Menopause Society that challenges the previous negative views on hormone replacement therapy (HRT) for women over the age of 65.

The study found that HRT, specifically estrogen therapy, beyond the age of 65 is associated with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia. The study also highlighted the importance of individualized hormone therapy, lower doses, and non-oral routes of administration for optimal health outcomes.

Episode Highlights

  • Hormone replacement therapy (HRT) beyond the age of 65
  • Results of a new study published by NAMS
  • How they're associating HRT with significant risk reductions in mortality, breast cancer, lung cancer, colorectal cancer, congestive heart failure, venous thromboembolism, atrial fibrillation, heart attacks, and dementia
  • Individualized hormone therapy, lower doses, and non-oral routes of administration are recommended for optimal health outcomes.
  • Estrogen-only therapy, specifically transdermal estrogen with progesterone, is beneficial and prolongs life.
  • The study challenges the previous negative views on HRT for women over the age of 65 and provides evidence for the benefits of hormone therapy in improving women's health.
  • Why women should discuss hormone therapy options with their healthcare providers and consider the potential benefits and risks based on their individual needs and health conditions.

Resources

Dr. Shawn Tassone's Practice | Tassone Advanced Gynecology

Dr. Shawn Tassone's Book | The Hormone Balance Bible

Dr. Shawn Tassone's Integrative Hormonal Mapping System | Hormonal Archtype Quiz

Medical Disclaimer

This podcast and website represent the opinions of Dr. Shawn Tassone and his guests. The content here should not be taken as medical advice and is for informational purposes only. Because each person is so unique, please consult your health care professional for any medical questions.

  continue reading

106 epizódok

Minden epizód

×
 
Loading …

Üdvözlünk a Player FM-nél!

A Player FM lejátszó az internetet böngészi a kiváló minőségű podcastok után, hogy ön élvezhesse azokat. Ez a legjobb podcast-alkalmazás, Androidon, iPhone-on és a weben is működik. Jelentkezzen be az feliratkozások szinkronizálásához az eszközök között.

 

Gyors referencia kézikönyv